Study Provides Real-World Evidence for Inflammatory DED - Summary - MDSpire
Advertisement
Study Provides Real-World Evidence for Inflammatory DED
Carolina L. Mercado, MD, and colleagues presented data from the American Academy of Ophthalmology IRIS (Intelligent Research in Sight) Registry linked to pharmacy claims data sourced from the Komodo Health Research Dataset.
To evaluate the characteristics, treatment, and diagnostic practices for patients with dry eye disease (DED) using real-world data, focusing on those diagnosed on or after January 1, 2016.
Approach:
Key Findings:
Predominantly female population (80%) with a mean age of 61 years.
Cataract was the most common ocular comorbidity; hyperlipidemia (45%) and hypertension (43%) were the most common nonocular comorbidities.
Only 10% of patients had used other therapies prior to lifitegrast, indicating a large untreated population.
Dry eye diagnostic testing was underutilized; only 3.9% had an abnormal tear breakup time.
Racial distribution included approximately 55% White, 5% Black, 5% Asian, 9% other, and 25% unknown.
Interpretation:
The study reveals significant comorbidities in DED patients and highlights the underutilization of diagnostic testing, indicating a need for improved management strategies to address these gaps.
Limitations:
The study may not fully represent all demographics due to the predominance of certain racial and ethnic groups, potentially affecting the generalizability of the findings.
Data on diagnostic tests was incomplete, with a high percentage of unknown results.
Conclusion:
This real-world study underscores the need for better diagnostic practices and treatment strategies for DED patients.